These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7945466

  • 1. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.
    Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB.
    Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466
    [Abstract] [Full Text] [Related]

  • 2. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    Clin Dev Immunol; 2006 Oct; 13(2-4):283-7. PubMed ID: 17162369
    [Abstract] [Full Text] [Related]

  • 3. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.
    Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
    [Abstract] [Full Text] [Related]

  • 4. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K, Hamzaoui A, Zakraoui L, Chabbou A.
    Mediators Inflamm; 1999 Feb; 8(2):101-6. PubMed ID: 10704147
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance and expression of Bcl-2 protein in patients with systemic lupus erythematosus].
    Liu Y, Yin P, Zhao X, Shi C, Kong Q, Guan W.
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):94-7. PubMed ID: 11798633
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus.
    Graninger WB.
    Wien Klin Wochenschr; 1992 Feb; 104(7):205-7. PubMed ID: 1523845
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus.
    Falcini F, Azzari C, Gelli VA, Luchetti M, Gabrielli A, Calzolari A, Pignone A, Generini S, Matucci Cerinic M.
    Clin Immunol; 1999 Oct; 93(1):59-64. PubMed ID: 10497011
    [Abstract] [Full Text] [Related]

  • 9. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
    Rose LM, Latchman DS, Isenberg DA.
    Br J Rheumatol; 1995 Apr; 34(4):316-20. PubMed ID: 7788144
    [Abstract] [Full Text] [Related]

  • 11. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus.
    Chan EY, Ko SC, Lau CS.
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):3-7. PubMed ID: 9251841
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 13. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Apr; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 14. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y, Ogaki M, Abe K, Takeuchi K, Ando S, Tokano Y, Kobayashi S, Sekigawa I, Tsuda H, Hashimoto H.
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death.
    Tamaru Y, Miyawaki T, Iwai K, Tsuji T, Nibu R, Yachie A, Koizumi S, Taniguchi N.
    Blood; 1993 Jul 15; 82(2):521-7. PubMed ID: 8329707
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H.
    Arthritis Rheum; 1998 May 15; 41(5):823-30. PubMed ID: 9588733
    [Abstract] [Full Text] [Related]

  • 19. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.
    Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M.
    Lupus; 1998 May 15; 7(2):113-8. PubMed ID: 9541096
    [Abstract] [Full Text] [Related]

  • 20. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 15; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.